LETTER
1984, 25, 577. (c) Kondo, K.; Umemoto, T.; Takahatake, Y.;
Tunemoto, D. Tetrahedron Lett. 1977, 23, 113.
(8) Meinwald, J.; Crandall, K. J. Am. Chem. Soc. 1966, 88,
1292.
(9) Smith, A. B.; Scarborough, R. M. Jr. Tetrahedron Lett. 1978,
1649.
(10) Scarborough, R. M. Jr.; Toder, B. H.; Smith, A. B. III. J. Am.
Chem. Soc. 1980, 102, 3904.
(11) (a) Nazari, M.; Movassagh, B. Tetrahedron Lett. 2009, 50,
1453. (b) Nazari, M.; Movassagh, B. Tetrahedron Lett.
2009, 50, 438. (c) Movassagh, B.; Tatar, A. Synlett 2007,
1954. (d) Movassagh, B.; Mirshojaei, F. Monatsh. Chem.
2003, 134, 831. (e) Movassagh, B.; Shamsipoor, M. Synlett
2005, 1316. (f) Movassagh, B.; Fazeli, A. Z. Naturforsch., B
2006, 61, 194. (g) Movassagh, B.; Shamsipoor, M.;
Joshaghani, M. J. Chem. Res., Synop. 2004, 148.
(h) Movassagh, B.; Shamsipoor, M. Synlett 2005, 127.
(i) Movassagh, B.; Fazeli, A. Monatsh. Chem. 2007, 138,
863.
Ring Opening of Mono-Activated Cyclopropanes
1805
52.95; H, 5.35. Compound 4f: IR (neat): 1714 cm–1. 1H
NMR (500 MHz, CDCl3): d = 1.96 (quin, J = 7.1 Hz, 2 H),
2.13 (s, 3 H), 2.59 (t, J = 7.0 Hz, 2 H), 2.91 (t, J = 7.2 Hz,
2 H), 7.24 (d, J = 8.5 Hz, 2 H), 7.43 (d, J = 8.5 Hz, 2 H)
ppm. 13C NMR (125 MHz, CDCl3): d = 23.9, 27.5, 30.0,
42.9, 128.2, 129.2, 133.1, 134.0, 207.7 ppm. LRMS: m/z
(%) = 278 (7) [M + 4]+, 276 (15) [M + 2]+, 274 (7) [M]+, 191
(4), 156 (3), 125 (3), 85 (100), 43 (86). Anal. Calcd for
C11H13ClOSe: C, 47.93; H, 4.75. Found: C, 47.83; H, 4.39.
Compound 4g: mp 100–101 °C. IR (KBr disk): 1709, 2450–
3500 cm–1. 1H NMR (300 MHz, CDCl3): d = 1.99 (quin,
J = 7.2 Hz, 2 H), 2.51 (t, J = 7.2 Hz, 2 H), 2.94 (t, J = 7.3 Hz,
2 H), 7.24 (d, J = 8.5 Hz, 2 H), 7.43 (d, J = 8.5 Hz, 2 H),
11.50 (br s, 1 H) ppm. 13C NMR (75 MHz, CDCl3): d = 24.8,
27.1, 33.5, 127.7, 129.3, 133.3, 134.2, 179.3 ppm. LRMS:
m/z (%) = 280 (10) [M + 4]+, 278 (24) [M + 2]+, 276 (11)
[M]+, 192 (21), 156 (16), 112 (24), 87 (100), 43 (44). Anal.
Calcd for C10H11ClO2Se: C, 43.27; H, 3.99. Found: C, 43.16;
H, 3.83. Compound 4h: IR (neat): 2246 cm–1. 1H NMR (500
MHz, CDCl3): d = 2.00 (quin, J = 7.0 Hz, 2 H), 2.51 (t,
J = 7.0 Hz, 2 H), 2.99 (t, J = 7.1 Hz, 2 H), 7.27 (d, J = 8.5
Hz, 2 H), 7.45 (d, J = 8.5 Hz, 2 H) ppm. 13C NMR (125
MHz, CDCl3): d = 17.1, 25.7, 26.4, 118.8, 127.0, 129.5,
133.9, 134.7 ppm. LRMS: m/z (%) = 261 (50) [M + 4]+, 259
(100) [M + 2]+, 257 (52) [M]+, 191 (14), 156 (14), 112 (11),
68 (14), 41 (27). Anal. Calcd for C10H10ClNSe: C, 46.44; H,
3.90; N, 5.42. Found: C, 46.73; H, 4.15; N, 5.58. Compound
4i: IR (neat): 1714 cm–1. 1H NMR (500 MHz, CDCl3):
d = 1.96 (quin, J = 7.1 Hz, 2 H), 2.13 (s, 3 H), 2.59 (t, J = 7.1
Hz, 2 H), 2.99 (t, J = 7.1 Hz, 2 H), 7.40 (t, J = 7.7 Hz, 1 H),
7.50–7.62 (m, 2 H), 7.78–7.89 (m, 3 H), 8.40 (d, J = 8.4 Hz,
1 H) ppm. 13C NMR (125 MHz, CDCl3): d = 24.0, 27.5,
29.7, 43.1, 125.8, 126.2, 126.6, 127.5, 128.3, 128.7, 129.2,
132.3, 134.1, 134.3, 207.9 ppm. LRMS: m/z (%) = 292 (17)
[M + 2]+, 290 (10) [M]+, 207 (6), 165 (6), 141 (6), 128 (15),
115 (17), 85 (100), 43 (99). Anal. Calcd for C15H16OSe: C,
61.86; H, 5.54. Found: C, 62.17; H, 5.76. Compound 4j: IR
(neat): 1708, 2400–3500 cm–1. 1H NMR (500 MHz, CDCl3):
d = 2.01 (quin, J = 7.2 Hz, 2 H), 2.53 (t, J = 7.3 Hz, 2 H),
3.02 (t, J = 7.2 Hz, 2 H), 7.41 (t, J = 7.7 Hz, 1 H), 7.51–7.63
(m, 2 H), 7.80–7.90 (m, 3 H), 8.45 (d, J = 8.4 Hz, 1 H),
11.41 (br s, 1 H) ppm. 13C NMR (125 MHz, CDCl3):
d = 25.0, 27.1, 33.8, 125.8, 126.3, 126.7, 127.6, 128.5,
128.7, 129.1, 132.5, 134.1, 134.4, 179.3 ppm. LRMS: m/z
(%) = 294 (87) [M + 2]+, 292 (47) [M]+, 208 (38), 141 (14),
128 (100), 115 (65), 87 (67), 43 (24). Anal. Calcd for
C14H14O2Se: C, 57.35; H, 4.81. Found: C, 56.99; H, 5.03.
(12) General Procedure: A mixture of diaryl diselenide (0.5
mmol) and zinc powder (3.0 mmol) in anhydrous MeCN (15
mL), was stirred at 70 °C. After 15 min, anhydrous AlCl3
(3.0 mmol in 2 mL anhydrous MeCN) was added cautiously.
The mixture was stirred for 1 h at 70 °C, until the yellow
solution turned colorless. The mono-activated cyclopropane
(1.1 mmol) was then added to the solution and the mixture
was stirred at 70 °C for the period of time specified in
Table 1. The progress of reaction was monitored with TLC.
After the reaction was complete, the solution was filtered
and the solvent was evaporated. Aqueous HCl (10%) was
added to the crude product and the mixture was extracted
with EtOAc (2 × 30 mL). The combined organic layers were
dried over anhydrous Na2SO4, filtered, and the solvent was
removed under reduced pressure. Purification by preparative
TLC (silica gel; n-hexane–EtOAc, 3:1) gave the corres-
ponding arylselenenyl-functionalized ring-opened product.
All novel compounds were characterized by 1H and 13
NMR, IR, mass spectroscopy, and elemental analysis.
C
Compound 4e: IR (neat): 1723, 2725, 2825 cm–1. 1H NMR
(500 MHz, CDCl3): d = 2.06 (quin, J = 6.9 Hz, 2 H), 2.64 (t,
J = 6.9 Hz, 2 H), 2.98 (t, J = 7.0 Hz, 2 H), 7.23–7.61 (m,
5 H), 9.80 (s, 1 H) ppm. 13C NMR (125 MHz, CDCl3):
d = 22.9, 27.5, 29.3, 127.5, 129.4, 129.6, 132.7, 201.8 ppm.
LRMS: m/z (%) = 227 (25) [M + 2]+, 225 (12) [M]+, 185
(45), 183 (22), 171 (32), 169 (15), 157 (78), 155 (42), 123
(53), 105 (31), 91 (100), 77 (78), 71 (58), 55 (45), 41 (49).
Anal. Calcd for C10H12OSe: C, 52.87; H, 5.32. Found: C,
Synlett 2009, No. 11, 1803–1805 © Thieme Stuttgart · New York